544 results match your criteria: "The David Geffen School of Medicine at UCLA[Affiliation]"
Kidney360
August 2025
Division of Nephrology, Hypertension and Transplantation and The Lundquist Institute at Harbor-UCLA Medical Center, the David Geffen School of Medicine at UCLA and the UCLA Fielding School of Public Health, Torrance and Los Angeles, California.
Cell
June 2025
Department of Neurology, the David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA. Electronic address:
Vascular dementia (VaD), the second-leading cause of dementia, is primarily a white matter ischemic disease with no direct therapies. Cell-cell interactions within lesion sites dictate disease progression or repair. To elucidate key intercellular pathways, we employ a VaD mouse model with focal ischemia replicating many elements of the complex pathophysiology of human VaD combined with transcriptomic and functional analyses.
View Article and Find Full Text PDFAnn Surg
September 2025
Patient-Reported Outcomes, Value, and Experience (PROVE) Center, Brigham and Women's Hospital, Boston, MA.
Objective: This study aimed to identify patient, surgeon, and hospital characteristics associated with inadequate shared decision-making (SDM) after surgery.
Background: SDM that incorporates patients' preferences, values, and goals is integral to setting expectations and delivering high-quality patient-centered surgical care.
Methods: This retrospective cohort study of 65 US hospitals analyzed data from the American College of Surgeons National Surgical Quality Improvement Program Patient-Reported Outcomes Measures Project.
J Headache Pain
January 2025
Department of Neurology, The David Geffen School of Medicine at UCLA, Los Angeles, USA.
Background: Migraine progression, particularly from episodic to chronic migraine (CM), increases disease burden and healthcare costs. Understanding the new concept of "Medication Underuse Headache" should encourage the health care provider to consider early intervention with calcitonin gene-related peptide (CGRP) monoclonal antibodies. Galcanezumab given early in the course of the disease, may prevent migraine chronification and have a robust response, moreso than when initiated in later stages of migraine.
View Article and Find Full Text PDFEndocrinology
February 2025
Division of Neonatology & Developmental Biology, Department of Pediatrics, UCLA Children's Discovery & Innovation Institute at the David Geffen School of Medicine at UCLA, Los Angeles, CA 90095-1752, USA.
To determine the basis for perinatal nutritional mismatch causing metabolic dysfunction-associated steatotic liver disease and diabetes mellitus, we examined adult phenotype, hepatic transcriptome, and pancreatic β-islet function. In prenatal caloric-restricted rats with intrauterine growth restriction (IUGR) and postnatal exposure to high fat with fructose (HFhf) or high carbohydrate, we investigated male and female IUGR-HFhf and IUGR-high carbohydrate, vs HFhf and control offspring. Males more than females displayed adiposity, glucose intolerance, insulin resistance, hyperlipidemia, and hepatomegaly with hepatic steatosis.
View Article and Find Full Text PDFUrol Pract
January 2025
The David Geffen School of Medicine at UCLA, Los Angeles, California.
Introduction: In the Los Angeles County Department of Health Services-the second largest public health care system in the United States-clinical integration allows specialists and primary care providers to collaboratively provide specialty care. We used time-driven activity-based costing to compare patient burden and cost of kidney stone diagnosis, workup, and management with and without clinical integration.
Methods: We interviewed and observed teams of physicians and staff to understand workflow practices and personnel, space, material, and device requirements for stone care in the 2 models.
Nat Rev Neurol
November 2024
Department of Neurology, The David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
J Addict Med
February 2025
From the David Geffen School of Medicine at UCLA, Los Angeles, CA (TA); Department of Internal Medicine, UCLA David Geffen School of Medicine, Los Angeles, CA (FV); UCLA Semel Institute, Los Angeles, CA (RM); Department of Psychiatry and Biobehavioral Science, UCLA, Los Angeles, CA (IM); and Departm
Drugs Real World Outcomes
September 2024
University of California, 101 The City Drive South, Building 26, Room 1000, Irvine, CA, 92868, USA.
Background: In patients with heart failure with reduced ejection fraction (HFrEF), lower discharge heart rate (HR) is known to be associated with better outcomes. However, the effect of HR control on patient outcomes, and the demographic and clinical determinants of this association, are not well documented.
Objectives: The purpose of this work was to evaluate the association between the HR control and the risk of post-discharge rehospitalization in patients hospitalized with HFrEF.
Cutis
May 2024
Brandon Smith is from the Drexel University College of Medicine, Philadelphia, Pennsylvania. Priya Engel is from the California University of Science and Medicine, Colton. Sogol Stephanie Javadi is from the David Geffen School of Medicine at UCLA, Los Angeles, California. Dr. Egeberg is from the Dep
J Neurooncol
September 2024
Department of Physiology, The David Geffen School of Medicine at UCLA, Los Angeles, CA, 90095-1751, USA.
Nat Commun
June 2024
Momentum Laboratory of Neuroimmunology, HUN-REN Institute of Experimental Medicine, Budapest, H-1083, Hungary.
JAMA Surg
September 2024
Division of Research and Optimal Patient Care, American College of Surgeons, Chicago, Illinois.
Importance: Patient-reported outcome measures (PROMs) are increasingly recognized for their ability to promote patient-centered care, but concerted health information technology (HIT)-enabled PROM implementations have yet to be achieved for national surgical quality improvement.
Objective: To evaluate the feasibility of collecting PROMs within a national surgical quality improvement program.
Design, Setting, And Participants: This was a pragmatic implementation cohort study conducted from February 2020 to March 2023.
Expert Rev Neurother
August 2024
Department of Neurology, The David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
Background: To identify the preferences and perceptions of migraine patients for acute and preventive treatment options and to investigate which treatment outcomes are the most important.
Design And Methods: The authors performed a choice-format survey in a cohort of migraine patients from Greece and Cyprus. A self-administered questionnaire developed in collaboration with the Greek Society of Migraine Patients was used.
Ann Surg
September 2024
Surgical Health Outcomes and Research for Equity (SHORE) Center, Department of Surgery, University of Rochester Medical Center, Rochester, NY.
Objective: To investigate the initial set of patient-reported outcomes (PROs) in the American College of Surgeons National Surgical Quality Improvement Program (NSQIP) and their associations with 30-day surgical outcomes.
Background: PROs provide important information that can be used to improve routine care and facilitate quality improvement. The American College of Surgeons conducted a demonstration project to capture PROs into the NSQIP to complement clinical data.
Acad Emerg Med
November 2024
Department of Pediatrics, University of Washington School of Medicine, Seattle, Washington, USA.
In this secondary analysis of a multicenter investigation, we describe several gaps in the collection and management of pediatric race, ethnicity, and language data. These findings highlight the ongoing need for reliable data management processes as a crucial step toward advancing pediatric health equity.
View Article and Find Full Text PDFCephalalgia
April 2024
Faculty of Medicine, King Mongkut's Institute of Technology Ladkrabang, Bangkok, Thailand.
Ann Emerg Med
July 2024
Department of Emergency Medicine, Ronald Reagan UCLA Medical Center, the David Geffen School of Medicine at UCLA, Los Angeles, CA; Olive View-UCLA Education and Research Institute, Los Angeles, CA.
Urogynecology (Phila)
March 2024
Departments of Urology and Obstetrics and Gynecology, Division of Female Pelvic Medicine and Reconstructive Surgery, David Geffen School of Medicine at UCLA, Los Angeles, CA.
Importance: Given worsening global antibiotic resistance, antimicrobial stewardship aims to use the shortest effective duration of the most narrow-spectrum, effective antibiotic for patients with specific urinary symptoms and laboratory testing consistent with urinary tract infection (UTI). Inappropriate treatment and unnecessary antibiotic switching for UTIs harms patients in a multitude of ways.
Objective: This study sought to analyze antibiotic treatment failures as measured by antibiotic switching for treatment of UTI in emergent and ambulatory care.
Background: Microgenia resulting from congenital deficiency or aging can significantly affect the facial profile and render it less attractive. This study assessed the effectiveness of treatment with incobotulinumtoxinA (Inco) and calcium hydroxylapatite with integral lidocaine (CaHA[+]) for improving chin profile.
Methods: Subjects with a hyperactive mentalis and at least moderate chin retrusion according to the Asian Chin Projection Scale (ACPS) were recruited.
Pediatrics
February 2024
Boston Medical Center, Boston University Chobanian and Avedisian School of Medicine, Boston, Massachusetts.
J Pediatr
April 2024
Section of Pediatric Emergency Medicine, Departments of Pediatrics and Emergency Medicine, Yale School of Medicine, New Haven, CT.
In this multicenter, cross-sectional, secondary analysis of 4042 low-risk febrile infants, nearly 10% had a contaminated culture obtained during their evaluation (4.9% of blood cultures, 5.0% of urine cultures, and 1.
View Article and Find Full Text PDFGynecol Oncol
February 2024
Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Objective: HER2 mutations are associated with poor prognosis and are detected in 3-6% of cervical cancers. Neratinib, an irreversible pan-HER tyrosine kinase inhibitor, had activity in several HER2-mutant cancer types in the phase 2 SUMMIT basket study. We present updated and final results from the cervical cancer cohort of SUMMIT.
View Article and Find Full Text PDFKey Clinical Message: Endometrial lymphoma is a rare etiology of abnormal uterine bleeding and endometrial thickening, and often shares similar clinical and imaging characteristics with other uterine malignancies such as endometrial carcinoma. Chemotherapy appears adequate for treating primary endometrial lymphoma.
Abstract: We report a case of primary endometrial diffuse large B-cell lymphoma to increase awareness of this condition which is essential for correct diagnosis and treatment.